Big pharma, Mitsubishi Tanabe has signed a pharma licensing agreement with Dezima Pharma with regards to the in-licensing of a cholesteryl ester transfer protein inhibitor DEZ-001.
Terms of this pharma licensing deal were not disclosed.
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies
Report: Partnering Deals and Alliances with Big Pharma
Report: Partnering Agreements with Mitsubishi Tanabe 2005-2012
Report: Partnering with Bigpharma
View: More articles on Mitsubishi
Report: Partnering Deals and Alliances with Mitsubishi Tanabe
View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk
Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now
Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now
Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more
For further deal information visit Current Agreements (subscription required)